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Understanding the global genetic diversity of
HIV is important for monitoring the spread of
infection and developing effective vaccines.
Currently, two principal genetic groups, desig-
nated M (main) and O (outlier), have been
identified. M, which is highly prevalent, is further
classified into 10 established envelope subtypes, A
through J (1). Mosaic forms, which combine the
genetic material from two distinct subtypes, have
also been identified (1,2). HIV-1 subtype B
predominates in Europe and the Americas,
whereas HIV-1 non-subtype B strains dominate in
sub-Saharan Africa. In contrast to HIV-1 infection,
which is spread through all continents, HIV-2 is
primarily re-stricted to West Africa and to
population move-ments from or through this
region. HIV-2 strains are classified into five
subtypes, A through E; only subtypes A and B
viruses are predominant (3).
HIV-subtype distribution patterns in regions
where HIV is not endemic are not well known (4).
Information about these distribution patterns is
important for 1) implementing proper diagnostic
assays to protect the blood supply, 2) providing
basic information on the prevalence of viral sub-
types for vaccine development, and 3) monitoring
trends of viral spread. Two distribution patterns of
HIV subtypes have been recognized in areas where
the disease had not been endemic. The first pattern
consists of a restricted number of HIV-1 viral sub-
types or their combination with HIV-2. Examples
include HIV-1 subtypes E and B in Thailand
(5) and HIV-1 subtype C and HIV-2 in India
(6). In contrast, the second pattern includes a
large number of only HIV-1 subtypes as
documented in Cyprus (A, B, C, F, and I) and the
Philippines (A, B, C, D, and E) (7,8). However,
information is limited as to how common the
spread of this HIV-subtype pattern is to areas in
which the disease is not endemic.
Lebanon was chosen for a genetic variability
study for three reasons. First, HIV is not endemic
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HIV genetic variability, phylogenetic relationships, and transmission dynamics were
analyzed in 26 HIV-infected patients from Lebanon. Twenty-five specimens were identified
as HIV-1 and one as HIV-2 subtype B. The 25 strains were classified into six env-C2-V3
HIV-1 subtypes: B (n = 10), A (n = 11), C (n = 1), D (n = 1), G (n = 1), and unclassifiable.
Potential recombinants combining parts of viral regions from different subtypes Aenv/Dpol/
Agag, Genv/Apol,  and the unclassifiable-subtypeenv/ unclassifiable-subtypepol/Agag were found
in three patients. Epidemiologic analysis of travel histories and behavioral risks indicated
that HIV-1 and HIV-2 subtypes reflected HIV strains prevalent in countries visited by
patients or their sex partners. Spread of complex HIV-subtype distribution patterns to
regions where HIV is not endemic may be more common than previously thought. Blood
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in Lebanon, but its presence is slowly increasing
(9,10). From 1984 (when the first case of AIDS was
identified) (11) to 1996, 400 cases of HIV infection
were reported to the Lebanon National AIDS
Control Program (J.E. Mokhbat, pers. comm.).
Second, Lebanon has a central geographic location,
strong historic links, and frequent population
movements to and from other countries. Third, the
potential for introduction of multiple HIV subtypes
is present given the large number of Lebanese
expatriates who return to Lebanon after living and
working in HIV-endemic regions such as Africa
(mainly West Africa).
Study Population
With informed consent, interviews and blood
samples were obtained from 26 HIV-seropositive
Lebanese citizens (17 men and 9 women) living
in Lebanon at the time of the study. They were
referred (in 1996) from both urban and rural
areas to the Medical Center of the American
University of Beirut or the Saint George Hospital
in Beirut, Lebanon.
Study Design
HIV-1 antibodies were discriminated from
HIV-2 antibodies by  a synthetic slot immunoblot
composed of recombinant viral proteins and
synthetic peptides (Genelavia Mixt, Peptilav 1-2,
HIV Blot 2.2-Diagnostic Biotechnology and New
LAV Blot II, Sanofi Diagnostic Pasteur, France).
Double-stranded viral DNA of nested
polymerase chain reaction (PCR)-amplified env
(C2-V3), pol (protease-prot), and gag (p24
fragment) from peripheral blood mononuclear
cells were direct sequenced (12,13). Comparative
phylogenetic analysis of two or three indepen-
dent viral regions enables identification of a
possible mosaic viral genome (2). The sequences
were aligned by use of the CLUSTAL multiple-
sequence alignment program (14). After regions
containing gaps were eliminated, the aligned
sequences were analyzed with the maximum
likelihood method by using the fastDNAml
program, which uses randomized data input and
global rearrangement (15). Additionally, the
neighbor-joining method (PHYLIP package
version 3.5c [16] or TREECON software [17]) was
used, with or without bootstrapping. The
stability of the trees topology was tested by
pruning, which consists of removing one species
from the alignment and rerunning the phyloge-
netic analysis. SIV-cpz sequences were used as
outgroup. All specimens were also screened for
HIV-2 DNA by nested-PCR amplification of viral
HIV-2 prot gene. The outer PCR primers were
DP20: 5¢ GACAGAGGACTTGCTGCA; nucle-
otide position: 2068-2083, HIV-2ROD, and DP21:
5¢ GGCCATTGTCTCAGTTTTGG; nucleotide po-
sition: 2435-2454. The inner primers were
DP26a: 5¢ CACCTCAATTCTCTCTTTGGA; nucle-
otide position: 2082-2102; and DP27:
5¢ TAGATTTAATGACATGCCTAA; nucleotide
position: 2360-2380. Analysis based on HIV-2
pol region is highly specific and allows
classification of HIV-2 sequences into phyloge-
netic subtypes (3,18,19).
Molecular Characteristics of HIV Infection
Of 26 patients, 25 were HIV-1 PCR-positive;
the remaining patient (LE25) was HIV-2 PCR-
positive and was classified as having subtype B
infection (Figure 1). No dual infections with
HIV-1 and HIV-2 strains were found.
Figure 1. Phylogenetic classification of HIV-2
sequence from Lebanese patient LE25 (arrow) basing
on the prot gene (GenBank accession no. AF026912).
The tree was generated by the maximum likelihood
method. Numbers at the branch nodes connected with
subtypes indicate bootstrap values. The distinct HIV-
2 subtypes are delineated. The scale bar indicates an
evolutionary distance of 0.10 nucleotides per position
in the sequence. Vertical distances are for clarity
only.651 Vol. 4, No. 4, OctoberDecember 1998 Emerging Infectious Diseases
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The comparative phylogenetic analysis of 25
HIV-1 specimens identified 23 cases with the
same subtype assignment for the env and pol
sequences and classified 22 as known subtypes A
(n = 10), B (n = 10), C (n = 1), D (n = 1) (Figure 2).
In contrast, the remaining specimen (LE7)
consisted of distinctively divergent pol and env
sequences (Figure 2a, b) as they failed to cluster
with known standard HIV-1 sequences, includ-
ing divergent env subtypes I and J (Figure 2c).
Intragene recombination within pol and env
sequences of specimen LE7 was not observed
when nucleotide signature patterns in HIV-1
subtypes were compared. Thus, this strain might
represent a potential novel HIV-1 subtype.
However,  gag sequence of this virus grouped into
HIV-1 subtype A, and this association was
supported by the bootstrap value of 90% (Figure
2d). Taken together, these results indicate that
LE7 viral genome has a mosaic pattern involving
elements of an unclassifiable-divergent strain
and subtype A (unclassifiableenv/ unclassifiablepol/
Agag). In addition, potential recombinant viruses
combining viral env, pol, and gag from different
subtypes were identified in two other specimens.
Two known recombinant patterns, Genv/Apol and
Aenv/Dpol/Agag, have been found in patients LE24
and LE9, respectively. However, a potential
recombinant is sometimes difficult to recognize,
especially between subtypes B and D viruses,
which are relatively closely related; specimen
LE22  illustrates such a situation. The protease
gene sequence, the most outside branch in this
clade, grouped weakly with subtype B (Figure 2a).
This association, however, was not stable by
analysis that used pruning techniques and not
supported by bootstrap analysis (only 48% value
as opposed to 72% without this sequence). These
data suggest that it is unlikely that LE22 prot is
subtype B, and because both env and gag
sequences clustered into subtype D, we have
classified this sample as subtype D.
Epidemiologic Characteristics
To better understand the transmission
dynamics and temporal introduction of these
HIV variants, we analyzed patients data
(demographics, behavioral risk, modes of
transmission, and travel histories) (Table).
Of eight male patients with subtype B HIV-1
infection, six traveled to Europe, the Americas,
Asia (Thailand), or different locations in the
Middle East. All reported sexual contacts abroad
either with commercial sex workers or homo-
sexual or bisexual men. Of the remaining two
patients, one traveled selectively to Africa and
had sexual contacts in Côte dIvoire and Nigeria,
whereas the other reported no travel outside
Lebanon and had no sexual contacts with
commercial sex workers. In contrast, all nine
male patients infected with non-subtype B HIV-
1, including three mosaic viruses, traveled to
Africa or the United Arab Emirates and reported
sexual contacts with commercial sex workers.
The behavioral risks of the female patients
differed substantially from those of the male
patients. All female patients were married, and
none reported high-risk activities or  contacts
with commercial sex workers. Moreover, all
female patients (except one [LE12], who had
acquired HIV-1 infection from blood transfusion)
reported that their spouses were HIV-infected
and traveled abroad with them or alone.
To determine if the female patients acquired
HIV infection from their spouses, we analyzed
available epidemiologic data on the spouses of
three female patients LE17, LE19, and LE13.
The female patients LE17 and LE19 were
spouses of patients LE18 and LE23, respectively.
These two couples, LE17/LE18 and LE19/LE23,
were infected with HIV-1 subtype A and subtype
B viruses, respectively (Figure 2b). In further
detailed pairwise analysis of viral DNA isolated
from the husband and wife, a small nucleotide
divergence of 3.1% within env and of 0.6% for
both  prot and gag (13,20) showed that in the first
couple viral strains were closely related. These
data are concordant with epidemiologic findings,
which strongly indicate that the husband was
the source of infection because of his high-risk
sexual activities with commercial sex workers
during travels to the United Arab Emirates. His
wife did not travel outside Lebanon and did not
report activities that would have placed her at
risk for HIV-1 infection. In the second couple
(LE19/LE23), however, only weak relation
between viral strains was observed (nucleotide
divergence of 9.8% within env and 2% within
prot). This could be due to many factors including
1) the time that elapsed from infection; 2)
transmission of different quasispecies to the
spouse; 3) detection of only major quasispecies by
direct sequencing, which differed in the couple;
and 4) a different source of HIV-1 infection in the
sex partner. The latter hypothesis was not
supported by epidemiologic data, which indi-652 Emerging Infectious Diseases Vol. 4, No. 4, OctoberDecember 1998
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Figure 2. Phylogenetic classification of HIV-1 sequences from Lebanese patients denoted with LE prefix
(GenBank accession nos. AF025691-AF025745). The trees were constructed on the basis of the DNA sequences
of prot (a), env (b and c), and gag (d) by the maximum likelihood method. Numbers at the branch nodes connected
with subtypes indicate bootstrap values. Env trees: (b) includes all 25 Lebanese sequences of 325 bp and
reference sequences from eight subtypes A through H; and (c) includes only Lebanese LE7 sequence of 216 bp
and marker sequences from subtypes A through J.653 Vol. 4, No. 4, OctoberDecember 1998 Emerging Infectious Diseases
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Figure 2. continued. Arrows indicate Lebanese samples that clustered in different lineages depending on which
parts of their genome were analyzed. The distinct HIV-1 subtypes are delineated. ? represents the unclassified
position of prot and env sequences of sample LE7. The scale bar indicates an evolutionary distance of 0.10
nucleotides per position in the sequence. Vertical distances are for clarity only.654 Emerging Infectious Diseases Vol. 4, No. 4, OctoberDecember 1998
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Table. Demographic, clinical, and behavioral information
Sex partner characteristics
Bi/homo-
Patient Gen- Age CD4/ WHO AIDS/   sexual Travel/sexual
no. dera (yrs) Statusb  mm3  classc HIV  male CSWd contacts abroad Subtype
LE1 M 37 M 172 3 No No Yes West Africa (Côte dIvoire)e    A
LE5 M 42 M NA 3 NKf No Yes West Africae    A
LE6 M 29 M 168 2 Yes No Yes West Africae    A
LE11 M 26 S   44 3 Yes No Yes Africae    A
LE18g M 34 M 400 1 Yes No Yes Middle East (United    A
   Arab Emirates)e
LE22 M 42 S NA 3 No No Yes West Africa (Côte d'Ivoire)e    D
LE9 M 57 M 253 1 No No Yes Middle East (United Arab A/D/Ah
  Emirates)e,  Asia, Europe,
  North America
LE24 M 54 M 180 1 NK No Yes West Africa (Nigeria)e G/Ai
LE7 M 54 M 177 3 No No Yes West Africa (Côte NC/Aj
  dIvoire)e, Middle East
LE16 M 32 M   86 2 NK No Yes Europe    B
LE26 M 36 M   86 1 No No Yes Europe (France)e    B
LE2 M 27 S 396 3 Yes Yes No Europe (France, Germany,    B
  UK)e, North America
  (USA)e, Middle East
LE8 M 43 S   98 3 No Yes No Europee, South America,    B
  Middle East (Bahrain)e
LE10 M 35 S   56 4 No Yes No Europe (France)e,   B
  Middle East
LE14 M 45 D/SP     7 3 No No Yes Europe (Spain, Germany)e,   B
Asia (Thailand)e, South
  America
LE23k M 47 M NA 1 Yes No Yes West Africa (Côte d'Ivoire,    B
  Nigeria)e
LE21 M 31 S 340 1 No No No Lebanon only    B
LE3 F 31 M 378 1 Yes No No Lebanon only    A
LE17g F 32 M 300 3 Yes No No Lebanon only    A
LE20 F 32 M NA 1 Yes No No Europe    A
LE4 F 36 M 233 1 Yes No No Africa    A
LE13 F 35 M 350 1 Yes No No West Africa    A
LE15 F 34 M 171 1 Yes No No Asia    C
LE12l F 31 M 109 3 NK NK NK Africa    B
LE19k F 42 M   30 4 Yes No No West Africa    B
LE25 F 28 M 200 2 Yes No No West Africa HIV-2
aM=male, F=female.
bM=married, S=single, D/SP=divorced/separated.
cWorld Health Organization classification based on opportunistic infections.
dCommercial sex worker.
eSexual contact reported in region, country listed in parentheses.
fNot known.
gCouple no. 1.
hSubtype A -env, subtype D -pol, subtype A -gag.
iSubtype G -env, subtype A -pol.
jUnclassified subtype for env and pol, subtype A - gag.
kCouple no. 2.
lReported to be infected by blood transfusion.655 Vol. 4, No. 4, OctoberDecember 1998 Emerging Infectious Diseases
Dispatches
cated that only the husband was involved in
high-risk sexual activities in and outside
Lebanon. The third female patient, LE25, was
infected with HIV-2 subtype B strain. Her
husband, who died of AIDS-related complications,
had traveled to Côte dIvoire, a region in which this
HIV variant is endemic (21). These data suggest
that very likely the female patients acquired
infections from their HIV-infected spouses.
The molecular and epidemiologic data
indicate multiple HIV-1 introductions to Leba-
non. First, most male patients were infected
abroad with the HIV-1 strains prevalent in the
geographic region they visited. Second, the
topology of HIV-1 env subtype A demonstrated
that viral sequences of patients who had sexual
contacts with persons from West Africa clustered
in the branch with marker sequences from Côte
dIvoire. In contrast, HIV-1 sequences of patients
who reported contacts with persons from the
United Arab Emirates (LE9 and LE18) clustered
in another branch with Ugandan/Kenyan
marker sequences (Figure 2b). Independent
branching of HIV-1 env sequences of subtype A
from West and East Africa had been observed
(22). Third, the structures of two mosaic viral
genomes and epidemiologic data of patients
suggested that they were infected with potential
recombinant viruses, which had been identified
in two geographic regions. Briefly, patients LE24
and LE9, who reported sexual contacts with
commercial sex workers in Nigeria or the United
Arab Emirates, respectively, have been infected
with mosaic viruses Genv/Apol and Aenv/Dpol/Agag.
Such recombination patterns were found in
West-Central Africa and East Africa, respec-
tively (23,24). Finally, analysis of env sequences
from Lebanese patients revealed a relatively
high intrasubtype genetic diversity within
subtype B (average 14.9%, range 4.2% to 25.6%)
and subtype A (15.5%, range 2.5% to 28.9%).
Epidemiologic data and a low prevalence of HIV-1
infection suggest multiple introductions (rather
than long existence) of genetically diverse HIV-1
strains to Lebanon.
Conclusions
The results presented in this report provide
new information on HIV genetic variation in
Lebanon. The identification of HIV-2 and 6 env
HIV-1 subtypes, including three distinct HIV-1
mosaics, confirms high heterogeneity of HIV
variants in Lebanon. Given the limited number
of samples tested, finding both HIV-2 and
multiple HIV-1 subtypes is remarkable and
indicates that the distribution pattern of HIV
variants resembled that of Cyprus or the
Philippines rather than that of Thailand or
India. These data indicate that the spread of
complex HIV-subtype distribution patterns
involving a large number of distinct HIV-1 and
HIV-2 strains to countries without endemic HIV
may be more common than previously thought.
The HIV-2 infection detected in this study,
the first documented in Lebanon, reiterates the
importance of appropriate screening methods for
detecting both HIV-1 and HIV-2 to protect the
blood supply. Our findings provide preliminary
information for monitoring the spread of HIV
variants in Lebanon and developing subtype-
specific subunit vaccines.
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